Search the Newsroom
Filter By
News Type
Showing 1 - 10 of 20 results
Children’s Hospital of Philadelphia Researchers Find Pediatric Brain Tumor Survivors Are At-Risk for Social Deficits, Fewer Friendships, and Poor Peer Relationships
In a recent study, researchers at Children’s Hospital of Philadelphia (CHOP) demonstrated that children treated for brain tumors face persistent social challenges, including limited friendships and reduced peer acceptance, extending into adulthood. The study is the first to link disruptions in white matter connectivity to impaired social functioning in survivors of pediatric brain tumors.
Two CHOP Studies Find Role for ALT in Treatment-Resistant CNS Tumors
Two recent papers from CHOP cancer researchers have advanced the understanding of treatment-resistant pediatric central nervous system tumors.
Harnessing Data to Accelerate Discovery and Treatment of Brain Tumors
Through collaboration with research partners, patients, foundations, and community members, we are working to defeat childhood brain cancer and find better treatments for current patients. Read about recent milestones we’ve hit to accelerate pediatric brain tumor research.
CHOP Study Offers Proof of Concept for Treating Pediatric Brain Tumors with Immunotherapy
CHOP researchers have identified a protein on the surface of multiple pediatric brain tumors that they can target using immunotherapy in preclinical models.
CHOP, a PTEN Foundation Center of Excellence, Hosts PTEN Conference
As a designated PTEN Center of Excellence, CHOP offers the highest standards in multidisciplinary care.
CHOP and COG Will Validate New Tool to Measure NF1-Related Progressive Vision Loss
CHOP researchers will use optical coherence tomography (OCT) to measure vision changes associated with NF1-related optic pathway gliomas.
CHOP Participates in a Multi-institutional Clinical Trial Leading to First-Ever Therapy for Neurofibromatosis Type 1
New therapy shrinks tumors associated with NF1 and improves quality of life.
Two CHOP Physicians Present at PTEN Symposium
Drs. Adams and MacFarland among select group of conference speakers.
New Treatment Shows Success in High-Risk Solid Tumors
The CHOP-engineered therapy overcomes common drug resistance and has potential to elicit fewer toxicities than most cancer treatments.
Cancer Predisposition in Children: Increasing Awareness
A CHOP program is focused on identifying children who are predisposed to develop cancer and using surveillance testing to detect cancers early.